Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hulme

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Circulation. Cardiovascular Genetics|December 15, 2017
Heritability of Atrial FibrillationLu-Chen Weng, Seung Hoan Choi, Derek Klarin, et al.
Circulation. Arrhythmia and Electrophysiology|February 21, 2020
Initial Precipitants and Recurrence of Atrial FibrillationElizabeth Y Wang, Olivia L Hulme, Shaan Khurshid, et al.
Clinical Cardiology|September 7, 2020
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) RegistryAdam N Berman, David W Biery, Curtis Ginder, et al.
Pulmonary Circulation|December 19, 2017
The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking studyTakahiro Sato, Bharath Ambale-Venkatesh, Joao A C Lima, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2015
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial HypertensionPaul M Hassoun, Roham T Zamanian, Rachel Damico, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Circulation. Cardiovascular Genetics|December 15, 2017
Heritability of Atrial FibrillationLu-Chen Weng, Seung Hoan Choi, Derek Klarin, et al.
Circulation. Arrhythmia and Electrophysiology|February 21, 2020
Initial Precipitants and Recurrence of Atrial FibrillationElizabeth Y Wang, Olivia L Hulme, Shaan Khurshid, et al.
Clinical Cardiology|September 7, 2020
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) RegistryAdam N Berman, David W Biery, Curtis Ginder, et al.
Pulmonary Circulation|December 19, 2017
The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking studyTakahiro Sato, Bharath Ambale-Venkatesh, Joao A C Lima, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2015
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial HypertensionPaul M Hassoun, Roham T Zamanian, Rachel Damico, et al.
Pageof 3